TG Therapeutics Inc (NAS:TGTX)
$ 16.48 -0.94 (-5.4%) Market Cap: 2.55 Bil Enterprise Value: 2.45 Bil PE Ratio: 74.91 PB Ratio: 15.91 GF Score: 75/100

Q2 2021 TG Therapeutics Inc Earnings Call Transcript

Aug 02, 2021 / 12:30PM GMT
Release Date Price: $27.42 (-21.63%)
Operator

Greetings. Welcome to TG Therapeutics Second Quarter 2021 Earnings Call and Business Update. (Operator Instructions). Please note this conference is being recorded. At this time, I'll now turn the conference over to Jenna Bosco, Senior Vice President, Corporate Communications. Jenna, you may now begin.

Jenna Bosco
TG Therapeutics, Inc. - VP of IR & Senior VP of Corporate Communications

Thank you. Welcome, everyone, and thanks for joining us this morning. I'm Jenna Bosco, and with me today to discuss the second quarter 2021 financial results and provide a business update are Michael Weiss, our Chairman and Chief Executive Officer; Adam Waldman, our Chief Commercialization Officer; and Sean Power, our Chief Financial Officer.

Following our safe harbor statement, Mike will provide an overview of our recent corporate developments as well as an update on our current pivotal programs and remaining key goals for 2021. Adam will then provide an update on our commercialization efforts, and Sean will provide a brief overview of our financial results before

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot